Authors | Study | Localization | Nr. of Lesions | Nr. of Fractions | Total Dose (Gy) | LC @ 1Â year | Median OS (months) | Late Toxicity |
---|---|---|---|---|---|---|---|---|
Tse [34] | P | IHCC EHCC | 10 0 | 6 | 28-48 | 65% | 15 | 1 biliary obstruction 1 bowel obstruction |
Goodman [29] | P | IHCC EHCC | 5 0 | 1 | 18-30 | 77% | 28.6 | None |
Polistina [28] | R | IHCC EHCC | 0 10 | 3 | 30a | 80%b | 35.5 | 1 ulceration 2 stenosis |
Ibarra [35] | R | IHCC EHCC | 11 0 | 3 | 22-50 | 55.5% | 11 | 3 Grad 3 |
Barney [36] | R | IHCC EHCC | 6 4 | 3-5 | 45-60 | 100% | 15.5 | 1 Grade 3 biliary stenosis, 1 Grade 5 liver failure |
Momm [22] | R | IHCC EHCC | 0 13 | 10-12 | 32-56 | 78% | 33.5 | 1 Grade 3 5 cholangitis |
Weiner [37] | P | IHCC EHCC | 12 0 | 5 | 40-55 | 91%§ | 13.2 | 1 hepatic failure§ 1 biliary stricture |
Kopek [27] | R | IHCC EHCC | 26 1 | 3 | 45 | 85% | 10.6 | 6 ulcerations 3 stenosis |
Mahadevan [30] | R | IHCC EHCC | 31 11 | 3-5 | 24-45 | 88% | 17 | 4 Grade 3 (ulceration, cholangitis, abscess) |
Sandler [26] | R | IHCC EHCC | 6 25 | 5 | 40 | 78% | 15.7 | 5 Grade ≥ 3 |
Jung [25] | R | IHCC EHCC | 33 25± | 1-5 | 15-60 | 85% | 10 | 6 Grade 3 (ulceration, cholangitis, stenosis, perforation) |
Current | R | IHCC EHCC | 17 26 | 3-12 | 21-66 | 78% | 14 | 3 Grade ≥ 3 |